HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 47 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $509,736 | +258649.2% | 656,453 | 0.0% | 0.00% | – |
| Q4 2022 | $197 | -99.9% | 656,453 | -0.3% | 0.00% | – |
| Q3 2022 | $332,000 | -11.7% | 658,110 | 0.0% | 0.00% | – |
| Q2 2022 | $376,000 | -55.7% | 658,110 | 0.0% | 0.00% | – |
| Q1 2022 | $848,000 | +13.1% | 658,110 | 0.0% | 0.00% | – |
| Q4 2021 | $750,000 | -25.4% | 658,110 | 0.0% | 0.00% | – |
| Q3 2021 | $1,006,000 | -22.0% | 658,110 | +1.0% | 0.00% | – |
| Q2 2021 | $1,289,000 | +19.0% | 651,318 | +10.6% | 0.00% | – |
| Q1 2021 | $1,083,000 | +144.5% | 588,718 | +190.6% | 0.00% | – |
| Q4 2020 | $443,000 | +804.1% | 202,555 | +1183.1% | 0.00% | – |
| Q3 2020 | $49,000 | -66.9% | 15,786 | -43.3% | 0.00% | – |
| Q4 2019 | $148,000 | – | 27,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
| Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |